Loading...
Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker
There is an increased interest in finding predictive biomarkers that can guide treatment options for both mutation carriers and non-carriers. The statistical assessment of variation in treatment benefit (TB) according to the biomarker carrier status plays an important role in evaluating predictive b...
Na minha lista:
| Udgivet i: | Clin Cancer Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4856220/ https://ncbi.nlm.nih.gov/pubmed/27141007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2517 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|